Teen-to-adult ALL study using a pediatric chemotherapy plan
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a treatment plan for newly diagnosed acute lymphoblastic leukemia (ALL) in people ages 16 to 50. It aims to see how well a “pediatric-style” regimen works, but it only fits certain genetic and health profiles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 16 to 50 years old
- Have newly diagnosed ALL (not previously treated), with enough leukemia cells in blood or bone marrow (at least 20%)
- Your ALL should be Philadelphia-chromosome negative (unless you had limited pre-treatment like hydroxyurea, steroid tablets/infusions, or medicines given into the spinal fluid)
- You cannot have prior intravenous (vein) chemotherapy, though limited medicines before diagnosis may be allowed
- You must not have major health limits such as severe heart failure, very high liver enzymes or bilirubin, or significantly reduced kidney function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a standard chemotherapy regimen for people aged 18 to 50 with a type of leukemia called Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). It aims to see how well the treatment works for this age group.
This study follows how well a “pediatric-style” treatment plan works in teens and young adults with Ph-negative acute lymphoblastic leukemia (ALL) in real-world care. It mainly aims to understand outcomes and safety for patients who fit the specific leukemia and health criteria.
This trial tests a treatment plan for adults aged 18 to 65 who have just been diagnosed with a type of acute lymphoblastic leukemia (ALL) that does not have the Philadelphia chromosome (Ph-negative). The goal is to see how well this therapy works and how safe it is.
This trial tests a treatment plan for children with newly diagnosed acute lymphoblastic leukemia (ALL) that is considered standard-risk. It aims to see if the treatment is effective and safe.
This trial tests a treatment plan for people with a certain type of acute lymphoblastic leukemia (ALL) called B-lineage ALL. It aims to see how well the treatment works and how safe it is.
This trial tests a new treatment plan for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It aims to see if the combination of drugs can effectively control the leukemia while keeping side effects manageable.
Hear when a new Acute Lymphoid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.